GO:0050992 dimethylallyl diphosphate biosynthetic process: Isoprenoid Precursor Pathway, Genes, Functions and Research Methods

Research-grade guide for scientists and biopharma professionals

Key Takeaways

GO:0050992 describes the biological process that produces dimethylallyl diphosphate (DMAPP), the universal starter unit for all isoprenoids.
DMAPP is synthesized either via the mevalonate (MVA) pathway or the methylerythritol phosphate (MEP/DOXP) pathway, depending on the organism.
In plants, DMAPP is a substrate for cytokinin biosynthesis by dimethylallyl diphosphate:ATP/ADP isopentenyltransferases.
Type II IDI-2 isomerases interconvert IPP and DMAPP using flavin-dependent acid/base chemistry.
Nudix hydrolases can hydrolyze IPP/DMAPP to regulate isoprenoid flux in archaea and other organisms.
DMAPP biosynthesis is essential for terpenoid production in cyanobacteria and plants, with biotechnological applications.

Description

Dimethylallyl diphosphate (DMAPP) is a central metabolite in the biosynthesis of all isoprenoids, a vast class of natural products that includes sterols, carotenoids, and cytokinins. The Gene Ontology term GO:0050992, dimethylallyl diphosphate biosynthetic process, defines the set of biochemical reactions that lead to the formation of DMAPP. Understanding this process is fundamental for researchers in microbiology, plant biology, and metabolic engineering because DMAPP serves as the universal precursor for thousands of terpenoid compounds. The biosynthetic routes to DMAPP are evolutionarily distinct: the mevalonate pathway operates in animals, fungi, and some bacteria, while the methylerythritol phosphate (MEP) pathway is found in most bacteria, cyanobacteria, and plant plastids. In plants, DMAPP is also a substrate for cytokinin biosynthesis, linking isoprenoid metabolism to hormone signaling and growth regulation. Recent advances have revealed alternative two-step pathways for isoprenoid synthesis and novel non-squalene triterpenes, underscoring the ongoing relevance of DMAPP biosynthesis research.

dimethylallyl diphosphate biosynthetic process At A Glance

GO ID GO:0050992
GO term dimethylallyl diphosphate biosynthetic process
Ontology biological_process
Synonym dimethylallyl diphosphate anabolism; dimethylallyl diphosphate biosynthesis; dimethylallyl diphosphate formation; dimethylallyl diphosphate synthesis; dimethylallyl pyrophosphate biosynthesis; dimethylallyl pyrophosphate biosynthetic process; DPP biosynthesis; DPP biosynthetic process
Major function Production of DMAPP, the universal isoprenoid precursor
Key pathways Mevalonate (MVA) pathway; methylerythritol phosphate (MEP/DOXP) pathway; IPP-DMAPP isomerization
Key enzymes IDI-1, IDI-2, IPP isomerases, Nudix hydrolases, isopentenyltransferases
Organisms Bacteria, archaea, plants, animals, fungi
Related processes Terpenoid biosynthesis, cytokinin biosynthesis, carotenoid biosynthesis

What Is GO:0050992?

GO:0050992, dimethylallyl diphosphate biosynthetic process, is defined as the chemical reactions and pathways resulting in the formation of dimethylallyl diphosphate (DMAPP). This process encompasses both the mevalonate-dependent and mevalonate-independent (MEP/DOXP) routes, as well as the isomerization of isopentenyl diphosphate (IPP) to DMAPP. The term is a biological process in the Gene Ontology and includes synonyms such as DPP biosynthesis and dimethylallyl pyrophosphate biosynthetic process.

Why Is dimethylallyl diphosphate biosynthetic process Important in Cell Biology?

DMAPP biosynthesis is essential for life because it provides the fundamental building block for all isoprenoids, which include essential molecules such as cholesterol, steroid hormones, carotenoids, and the prenyl groups used in protein modification. In plants, DMAPP is directly used for cytokinin biosynthesis, influencing growth, development, and stress responses. In cyanobacteria, DMAPP-derived terpenoids play roles in photosynthesis and environmental adaptation. The pathway is also a target for antimicrobial and herbicidal drug development, as the MEP pathway is absent in humans. Furthermore, metabolic engineering of DMAPP biosynthesis enables sustainable production of high-value terpenoids, including pharmaceuticals and biofuels.
DMAPP is the universal precursor for all isoprenoids, including sterols, carotenoids, and prenylated proteins.
The MEP pathway for DMAPP biosynthesis is a validated target for antibiotics and herbicides due to its absence in humans.
In plants, DMAPP is a substrate for cytokinin biosynthesis, regulating cell division and shoot development.
Cyanobacterial DMAPP-derived terpenoids contribute to photosynthetic pigments and stress tolerance.
Type II IDI-2 isomerases provide a model for flavin-dependent acid/base catalysis.
Nudix hydrolases regulate IPP/DMAPP levels, affecting isoprenoid flux in archaea.
Alternative two-step pathways for isoprenoid synthesis offer new metabolic engineering strategies.
Non-squalene triterpenes discovered in plants expand the diversity of DMAPP-derived natural products.
Dysregulation of isoprenoid biosynthesis is linked to cardiovascular disease and cancer.
DMAPP biosynthesis is crucial for the production of artemisinin and other antimalarial drugs.

What Happens During dimethylallyl diphosphate biosynthetic process?

Mevalonate (MVA) Pathway
In simple terms: This is the classic route that builds DMAPP from acetyl-CoA in animals, fungi, and some bacteria.
The mevalonate pathway begins with the condensation of two acetyl-CoA molecules to form acetoacetyl-CoA, followed by a third acetyl-CoA to yield HMG-CoA. HMG-CoA reductase reduces HMG-CoA to mevalonate, which is then phosphorylated and decarboxylated to form IPP. IPP is subsequently isomerized to DMAPP by IPP isomerase. This pathway is the primary source of DMAPP in animals and fungi and is the target of statin drugs.
Methylerythritol Phosphate (MEP/DOXP) Pathway
In simple terms: This is an alternative route used by most bacteria, cyanobacteria, and plant plastids that starts from pyruvate and glyceraldehyde-3-phosphate.
The MEP pathway, also known as the DOXP pathway, condenses pyruvate and glyceraldehyde-3-phosphate to form 1-deoxy-D-xylulose 5-phosphate (DOXP). Subsequent steps yield 2-C-methyl-D-erythritol 4-phosphate (MEP), which is converted to IPP and DMAPP through a series of reactions. This pathway is essential in cyanobacteria for terpenoid biosynthesis and is a promising target for antimicrobials because it is absent in humans.
IPP-DMAPP Isomerization
In simple terms: This step converts IPP into DMAPP, ensuring the right balance of both precursors for isoprenoid synthesis.
Isopentenyl diphosphate isomerases (IDIs) catalyze the reversible isomerization of IPP to DMAPP. Type I IDIs are metal-dependent and found in most organisms, while type II IDIs (IDI-2) are flavin-dependent and use acid/base chemistry. In the methanogenic archaeon Methanosarcina mazei, a Nudix hydrolase specifically hydrolyzes IPP/DMAPP, regulating their cellular levels.
Alternative Two-Step Pathway
In simple terms: A newly discovered shortcut can make isoprenoid precursors in just two steps, bypassing the canonical MVA or MEP pathways.
A two-step pathway for isoprenoid synthesis was recently described, in which isopentenyl phosphate kinase and an isomerase convert mevalonate-5-phosphate to IPP and DMAPP. This pathway offers a simplified route for metabolic engineering of isoprenoid production in heterologous hosts.
DMAPP in Cytokinin Biosynthesis
In simple terms: In plants, DMAPP is used to make cytokinin hormones, which control growth and development.
Dimethylallyl diphosphate:ATP/ADP isopentenyltransferases (IPTs) catalyze the transfer of the dimethylallyl group from DMAPP to ATP or ADP, forming isopentenyladenine nucleotides, the first committed step in cytokinin biosynthesis. This links DMAPP biosynthesis directly to plant hormone signaling and developmental regulation.

Key Genes Involved in GO:0050992 dimethylallyl diphosphate biosynthetic process

The following genes and proteins are experimentally validated participants in DMAPP biosynthesis and its regulation.
GeneMajor RoleResearch Relevance
IDI1Type I IPP isomerase, converts IPP to DMAPPTarget for metabolic engineering of isoprenoids
IDI2Type II flavin-dependent IPP isomeraseModel for acid/base catalysis in flavoenzymes
MVKMevalonate kinase, phosphorylates mevalonateDefects cause mevalonic aciduria
PMVKPhosphomevalonate kinasePart of MVA pathway
MVDMevalonate diphosphate decarboxylaseProduces IPP from mevalonate-5-diphosphate
DXS1-deoxy-D-xylulose-5-phosphate synthaseFirst enzyme of MEP pathway
DXR1-deoxy-D-xylulose-5-phosphate reductoisomeraseTarget of fosmidomycin
ispDMEP cytidylyltransferaseMEP pathway enzyme in bacteria
ispE4-diphosphocytidyl-2-C-methyl-D-erythritol kinaseMEP pathway enzyme
ispF2-C-methyl-D-erythritol 2,4-cyclodiphosphate synthaseMEP pathway enzyme
ispGHMB-PP synthaseMEP pathway enzyme
ispHHMB-PP reductase, produces IPP/DMAPPFinal step of MEP pathway
Nudix hydrolase (M. mazei)Hydrolyzes IPP/DMAPPRegulates isoprenoid flux in archaea
IPT (plant)Dimethylallyl diphosphate:ATP/ADP isopentenyltransferaseCytokinin biosynthesis
GGPPSGeranylgeranyl diphosphate synthaseUses DMAPP for prenyl chain elongation
FPPSFarnesyl diphosphate synthaseUses DMAPP for sterol biosynthesis
TPSTerpene synthasesConvert DMAPP-derived prenyl diphosphates to terpenes

How Is dimethylallyl diphosphate biosynthetic process Regulated?

DMAPP biosynthesis is regulated at multiple levels. In the MVA pathway, HMG-CoA reductase is the rate-limiting enzyme and is controlled by feedback inhibition and transcriptional regulation. In the MEP pathway, DXR is a key regulatory point, and its activity is modulated by metabolic intermediates. IPP isomerase activity is also regulated to maintain the IPP/DMAPP ratio. In plants, cytokinin biosynthesis via IPT enzymes is tightly regulated by developmental and environmental cues. Additionally, Nudix hydrolases can degrade IPP/DMAPP, providing a post-translational control mechanism.

dimethylallyl diphosphate biosynthetic process and Human Disease

GeneDisease / BiologyPotential Experimental Model
MVKMevalonate kinase deficiencyKnockout or point-mutation in human cell lines
IDI1Isoprenoid biosynthesis disordersOverexpression and knockout in HEK293 cells
DXRBacterial infectionsKnockout in E. coli or M. tuberculosis
IPTPlant developmental defectsKnockout in Arabidopsis thaliana
Nudix hydrolaseArchaeal isoprenoid regulationKnockout in Methanosarcina mazei
Mevalonate Kinase Deficiency
Mutations in the MVK gene cause mevalonate kinase deficiency, an autoinflammatory disorder characterized by recurrent fevers and elevated inflammatory markers. This disease highlights the importance of the MVA pathway in human health.
Cancer and Isoprenoid Metabolism
Dysregulated isoprenoid biosynthesis, including DMAPP production, contributes to cancer progression through increased prenylation of oncoproteins such as RAS. Inhibitors of the MVA pathway, such as statins, have been investigated for anticancer effects.
Infectious Diseases and MEP Pathway
The MEP pathway is essential for many pathogenic bacteria, including Mycobacterium tuberculosis and Plasmodium falciparum, but is absent in humans. This makes MEP enzymes attractive targets for antibiotics and antimalarials.
Plant Development and Cytokinin
In plants, DMAPP-derived cytokinins regulate shoot meristem activity and leaf senescence. Altered IPT expression leads to developmental abnormalities, linking DMAPP biosynthesis to plant growth.

From dimethylallyl diphosphate biosynthetic process-Related Genes to Experimental Models

Research QuestionSuitable Model
Does IDI1 knockout reduce DMAPP levels?CRISPR knockout in HeLa or HEK293 cells
Does a point mutation in IDI2 abolish isomerase activity?Point-mutation knock-in in E. coli
Can a tagged IDI1 be used for localization studies?Knock-in of FLAG or GFP tag in human cells
Does overexpression of DXS increase isoprenoid flux?Overexpression in cyanobacteria or E. coli
Does IPT knockout affect cytokinin levels?Knockout in Arabidopsis
Does Nudix hydrolase regulate IPP/DMAPP?Knockout in M. mazei

How to Study the dimethylallyl diphosphate biosynthetic process Process

MethodWhat It MeasuresTypical Application
LC-MS metabolomicsDMAPP and isoprenoid intermediatesQuantify pathway flux
Enzyme assaysIDI isomerase activityCharacterize enzyme kinetics
CRISPR knockoutGene essentialityValidate pathway genes
RNA-seqTranscript levels of pathway genesExpression profiling
ProteomicsProtein abundanceIdentify regulated enzymes
ComplementationFunctional rescueConfirm gene function
Isotopic labelingMetabolic fluxTrace DMAPP origin
Structural biologyEnzyme structureDesign inhibitors
Metabolomics and LC-MS
Liquid chromatography-mass spectrometry (LC-MS) is used to quantify DMAPP and other isoprenoid intermediates in cell extracts. This method enables direct measurement of pathway flux and enzyme activity.
Enzyme Activity Assays
Recombinant IDI enzymes can be assayed for isomerase activity using IPP and DMAPP as substrates, coupled with spectrophotometric or radiometric detection.
Genetic Knockout and Complementation
Knockout of MEP or MVA pathway genes in bacteria or yeast, followed by complementation with candidate genes, is a powerful approach to validate gene function.
Transcriptomics and Proteomics
RNA-seq and proteomics can reveal changes in expression of DMAPP biosynthetic enzymes under different conditions, such as stress or developmental stages.

How CRISPR Can Be Used to Study GO:0050992 dimethylallyl diphosphate biosynthetic process

Knockout

CRISPR knockout of IDI1, DXS, or other DMAPP biosynthetic genes can be used to create auxotrophic cell lines that require exogenous isoprenoids for growth. These models are valuable for studying pathway essentiality and for screening for bypass pathways.

Point Mutation

Point mutations in catalytic residues of IDI2 or DXR can be introduced via CRISPR to dissect enzyme mechanism. For example, mutation of the flavin-binding residue in IDI2 abolishes isomerase activity.

Knock-in

Knock-in of epitope tags (e.g., FLAG, GFP) at the endogenous IDI1 or DXS locus allows for real-time imaging and immunoprecipitation of these enzymes in their native context.

Overexpression

CRISPR activation (CRISPRa) or transgenic overexpression of DXS or IDI1 can boost DMAPP production, enhancing isoprenoid yields in metabolic engineering applications.

How EDITGENE Supports dimethylallyl diphosphate biosynthetic process Research

Researchers studying dimethylallyl diphosphate biosynthetic process-related genes often need to determine whether a candidate gene is causally involved in DMAPP production, how mutations affect enzyme function, and whether overexpression can enhance isoprenoid flux. EDITGENE provides a comprehensive suite of CRISPR-based services to address these questions with precision and reproducibility.
Contact EDITGENE today to design your custom CRISPR model for dimethylallyl diphosphate biosynthetic process research.

Frequently Asked Questions About dimethylallyl diphosphate biosynthetic process

GO:0050992 is the Gene Ontology term for dimethylallyl diphosphate biosynthetic process, the set of reactions that produce DMAPP, a key isoprenoid precursor.
Key genes include IDI1, IDI2, MVK, PMVK, MVD, DXS, DXR, ispD, ispE, ispF, ispG, ispH, and plant IPT genes.
DMAPP stands for dimethylallyl diphosphate, a five-carbon molecule that serves as the universal precursor for all isoprenoids.
DMAPP is synthesized via the mevalonate pathway or the MEP/DOXP pathway, and by isomerization of IPP to DMAPP.
IPP and DMAPP are isomers; IPP is isopentenyl diphosphate, and DMAPP is dimethylallyl diphosphate. They are interconverted by IPP isomerases.
In plants, DMAPP is used for cytokinin biosynthesis and for the production of carotenoids, chlorophylls, and other terpenoids.
Mutations in MVK cause mevalonate kinase deficiency; the MEP pathway is a target for antibiotics against tuberculosis and malaria.
LC-MS metabolomics, enzyme assays, CRISPR knockout, and isotopic labeling are common methods.
IDI-2 is a type II IPP isomerase that uses flavin-dependent acid/base chemistry to interconvert IPP and DMAPP.
Yes, CRISPR knockout, knock-in, and activation can be used to manipulate DMAPP pathway genes for metabolic engineering.

Conclusion

GO:0050992, dimethylallyl diphosphate biosynthetic process, is a fundamental metabolic pathway that supplies DMAPP for all isoprenoid biosynthesis. Its enzymes are conserved across bacteria, plants, and animals, and are implicated in human disease, plant development, and microbial pathogenesis. Understanding the regulation and engineering of this pathway has broad implications for medicine, agriculture, and biotechnology. EDITGENE offers advanced CRISPR tools to study and manipulate DMAPP biosynthesis in any experimental system.

References

  1. 1. Kakimoto T. 2002. [Cytokinin].. Tanpakushitsu Kakusan Koso 47(12 Suppl):1651-7 PMID: 12357630
  2. 2. Thibodeaux CJ et al.. 2017. The type II isopentenyl Diphosphate:Dimethylallyl diphosphate isomerase (IDI-2): A model for acid/base chemistry in flavoenzyme catalysis.. Arch Biochem Biophys 632:47-58 PMID: 28577910
  3. 3. Ishibashi Y et al.. 2022. Isopentenyl diphosphate/dimethylallyl diphosphate-specific Nudix hydrolase from the methanogenic archaeon Methanosarcina mazei.. Biosci Biotechnol Biochem 86(2):246-253 PMID: 34864834
  4. 4. Tao H et al.. 2022. Discovery of non-squalene triterpenes.. Nature 606(7913):414-419 PMID: 35650436
  5. 5. Kakimoto T. 2001. Identification of plant cytokinin biosynthetic enzymes as dimethylallyl diphosphate:ATP/ADP isopentenyltransferases.. Plant Cell Physiol 42(7):677-85 PMID: 11479373
  6. 6. Pattanaik B et al.. 2015. Terpenoids and their biosynthesis in cyanobacteria.. Life (Basel) 5(1):269-93 PMID: 25615610
  7. 7. Chatzivasileiou AO et al.. 2019. Two-step pathway for isoprenoid synthesis.. Proc Natl Acad Sci U S A 116(2):506-511 PMID: 30584096
  8. 8. Eisenreich W et al.. 2001. Deoxyxylulose phosphate pathway to terpenoids.. Trends Plant Sci 6(2):78-84 PMID: 11173292
Contact Us
*
*
*
*
How did you hear about us: